🇺🇸 FDA
Patent

US 11617742

Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

granted A61KA61K31/436A61K31/4745

Quick answer

US patent 11617742 (Methods of treating keratin hyperproliferation disorders using mTOR inhibitors) held by PALVELLA THERAPEUTICS, INC. expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PALVELLA THERAPEUTICS, INC.
Grant date
Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/436, A61K31/4745, A61K9/0014, A61K9/0019